Cargando…
Advances in Noninvasive Biomarkers for Nonalcoholic Fatty Liver Disease
Nonalcoholic fatty liver disease (NAFLD) currently represents one of the most common liver diseases worldwide. Early diagnosis and disease staging is crucial, since it is mainly asymptomatic, but can progress to nonalcoholic steatohepatitis (NASH) or cirrhosis or even lead to the development of hepa...
Autores principales: | Gîlcă-Blanariu, Georgiana-Emmanuela, Budur, Daniela Simona, Mitrică, Dana Elena, Gologan, Elena, Timofte, Oana, Bălan, Gheorghe Gh, Olteanu, Vasile Andrei, Ștefănescu, Gabriela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10672868/ https://www.ncbi.nlm.nih.gov/pubmed/37999211 http://dx.doi.org/10.3390/metabo13111115 |
Ejemplares similares
-
Risk Predictors of Advanced Fibrosis in Non-Alcoholic Fatty Liver Disease
por: Olteanu, Vasile-Andrei, et al.
Publicado: (2022) -
Sarcoidosis associated with infliximab therapy in ulcerative colitis: A case report
por: Gîlcă, Georgiana-Emmanuela, et al.
Publicado: (2017) -
Magnesium—A Potential Key Player in Inflammatory Bowel Diseases?
por: Gilca-Blanariu, Georgiana-Emmanuela, et al.
Publicado: (2022) -
Split-dose or hybrid nonsteroidal anti-inflammatory drugs and N-acetylcysteine therapy for prevention of post-retrograde cholangiopancreatography pancreatitis
por: Pavel, Laura, et al.
Publicado: (2019) -
New Insights into the Role of Trace Elements in IBD
por: Gîlcă-Blanariu, Georgiana-Emmanuela, et al.
Publicado: (2018)